A new vaccine called Provenge has just been accepted by the FDA, making it the first to be approved by the agency for men fighting advanced prostate cancer. While Provenge is not a cure, it has shown promise in extending the lives of patients.
Rudy Giuliani’s factually challenged claims about how he probably would have fared in his battle against prostate cancer had he sought treatment in Britain instead of America might have raised only a small stir, but, for his part, columnist Paul Krugman thinks it should have been a much bigger deal.